NEUROPACE, INC. Operating Income
NEUROPACE, INC. (NPCE) reported Operating Income of -$5.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-11
- NEUROPACE, INC. operating income (loss) for the quarter ending 2026-06-30 was -$5.14M.
- NEUROPACE, INC. operating income (loss) for the quarter ending 2026-03-31 was -$5.57M.
- NEUROPACE, INC. operating income (loss) for the quarter ending 2025-12-31 was -$1.77M.
- NEUROPACE, INC. operating income (loss) for the quarter ending 2025-09-30 was -$2.60M.
- NEUROPACE, INC. operating income (loss) for fiscal 2025 was -$16.34M.
- NEUROPACE, INC. operating income (loss) for fiscal 2024 was -$21.67M.
- NEUROPACE, INC. operating income (loss) for fiscal 2023 was -$27.17M.
- NEUROPACE, INC. operating income (loss) for fiscal 2022 was -$40.79M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.14M 10-Q · filed 2026-08-11 | -$10.75M 10-Q · filed 2026-08-11 | -$12.48M derived: sum of 3 quarters · filed 2026-08-11 | -$15.08M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | -$5.57M 10-Q · filed 2026-05-12 | -$7.33M derived: sum of 2 quarters · filed 2026-05-12 | -$9.94M derived: sum of 3 quarters · filed 2026-05-12 | -$18.12M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$4.37M derived: sum of 2 quarters · filed 2026-03-03 | -$12.56M derived: sum of 3 quarters · filed 2026-08-11 | -$16.34M 10-K · filed 2026-03-03 | ||
| 2025-09-30 | -$2.60M 10-Q · filed 2025-11-04 | -$10.79M derived: sum of 2 quarters · filed 2026-08-11 | -$14.57M 10-Q · filed 2025-11-04 | -$19.59M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$8.19M 10-Q · filed 2026-08-11 | -$6.82M 10-Q · filed 2025-08-12 | -$14.95M 10-Q · filed 2026-08-11 | -$11.97M 10-Q · filed 2025-08-12 | -$16.99M derived: sum of 3 quarters · filed 2026-08-11 | -$21.23M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$5.15M 10-Q · filed 2026-05-12 | -$8.80M derived: sum of 2 quarters · filed 2026-05-12 | -$13.04M derived: sum of 3 quarters · filed 2026-05-12 | -$19.27M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$7.90M derived: sum of 2 quarters · filed 2026-03-03 | -$14.13M derived: sum of 3 quarters · filed 2026-03-03 | -$21.67M 10-K · filed 2026-03-03 | ||
| 2024-09-30 | -$4.24M 10-Q · filed 2025-11-04 | -$10.47M derived: sum of 2 quarters · filed 2025-11-04 | -$18.02M 10-Q · filed 2025-11-04 | -$23.07M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | -$6.23M 10-Q · filed 2025-08-12 | -$13.78M 10-Q · filed 2025-08-12 | -$18.83M derived: sum of 3 quarters · filed 2025-08-12 | -$24.78M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$7.54M 10-Q · filed 2025-05-13 | -$12.60M derived: sum of 2 quarters · filed 2025-05-13 | -$18.55M derived: sum of 3 quarters · filed 2025-05-13 | -$26.40M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$11.00M derived: sum of 2 quarters · filed 2025-03-04 | -$18.86M derived: sum of 3 quarters · filed 2025-03-04 | -$27.17M 10-K · filed 2025-03-04 | ||
| 2023-09-30 | -$5.95M 10-Q · filed 2024-11-12 | -$13.80M derived: sum of 2 quarters · filed 2024-11-12 | -$22.12M 10-Q · filed 2024-11-12 | -$31.98M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$7.85M 10-Q · filed 2024-08-13 | -$16.17M 10-Q · filed 2024-08-13 | -$26.03M derived: sum of 3 quarters · filed 2024-08-13 | -$36.23M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | -$8.32M 10-Q · filed 2024-05-08 | -$18.18M derived: sum of 2 quarters · filed 2024-05-08 | -$28.38M derived: sum of 3 quarters · filed 2024-05-08 | -$39.35M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | -$9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$20.06M derived: sum of 2 quarters · filed 2024-03-05 | -$31.03M derived: sum of 3 quarters · filed 2024-03-05 | -$40.79M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | -$10.20M 10-Q · filed 2023-11-06 | -$21.17M derived: sum of 2 quarters · filed 2023-11-06 | -$30.93M 10-Q · filed 2023-11-06 | -$39.95M derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | -$10.97M 10-Q · filed 2023-08-08 | -$20.74M 10-Q · filed 2023-08-08 | -$29.75M derived: sum of 3 quarters · filed 2023-08-08 | -$35.99M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$9.76M 10-Q · filed 2023-05-04 | -$18.78M derived: sum of 2 quarters · filed 2023-05-04 | -$25.02M derived: sum of 3 quarters · filed 2023-05-04 | -$29.63M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$15.26M derived: sum of 2 quarters · filed 2023-03-02 | -$19.86M derived: sum of 3 quarters · filed 2023-03-02 | -$23.74M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | -$6.24M 10-Q · filed 2022-11-08 | -$10.85M derived: sum of 2 quarters · filed 2022-11-08 | -$14.72M 10-Q · filed 2022-11-08 | -$17.70M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$4.61M 10-Q · filed 2022-08-11 | -$8.48M 10-Q · filed 2022-08-11 | -$11.46M derived: sum of 3 quarters · filed 2022-08-11 | -$12.63M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$3.87M 10-Q · filed 2022-05-12 | -$6.86M derived: sum of 2 quarters · filed 2022-05-12 | -$8.02M derived: sum of 3 quarters · filed 2022-05-12 | -$11.47M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$4.15M derived: sum of 2 quarters · filed 2022-03-10 | -$7.59M derived: sum of 3 quarters · filed 2022-03-10 | -$13.05M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$1.17M 10-Q · filed 2021-11-10 | -$4.61M derived: sum of 2 quarters · filed 2021-11-10 | -$10.07M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$3.45M 10-Q · filed 2021-08-12 | -$8.90M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | -$5.46M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |